SkyView Investment Advisors’s Amgen AMGN Stock Holding History

SkyView Investment Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$278K	Sell	789 -446	-36%	-$159K	0.04%	250
2025 Q4	$404K	Sell	1,235 -196	-14%	-$62.2K	0.05%	234
2025 Q3	$404K	Hold	1,431	–	–	0.05%	232
2025 Q2	$397K	Buy	1,431 +163	+13%	+$46.2K	0.06%	219
2025 Q1	$395K	Buy	+1,268	New	+$374K	0.06%	216
2021 Q3	–	Sell	-1,024	Closed	-$255K	–	369
2021 Q2	$255K	Hold	1,024	–	–	0.12%	164
2021 Q1	$255K	Sell	1,024 -149	-13%	-$35.6K	0.11%	172
2020 Q4	$270K	Buy	+1,173	New	+$270K	0.13%	168

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

SkyView Investment Advisors's AMGN Position: Q1 2026 in Review

SkyView Investment Advisors reduced its Amgen (AMGN) stake by 36% in Q1 2026, selling an estimated $159K and leaving 789 shares worth $278K. The position accounts for 0.04% of the portfolio, ranked #250.

SkyView Investment Advisors first reported a position in AMGN in Q4 2020 and has held it in 8 quarters since. The position peaked at $404K in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

SkyView Investment Advisors held 789 shares of Amgen worth $278K as of Q1 2026.
SkyView Investment Advisors sold 446 Amgen shares in Q1 2026, an estimated $159K.
Amgen made up 0.04% of SkyView Investment Advisors's portfolio in Q1 2026, its #250 holding.
SkyView Investment Advisors first reported a position in Amgen in Q4 2020 and has held it in 8 quarters since.
SkyView Investment Advisors's Amgen position peaked at $404K in Q4 2025.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on SkyView Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.